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ABSTRACT 
 
Objective: The objective of this EBM paper is to determine whether or not hypnotherapy is an 
effective treatment for depression. 
 
Study Design: Review of two English language randomized controlled trials and one case study 
published in 2007, 2009, and 2010. 
 
Data Sources: Two randomized controlled trials and one case study reviewing the effectiveness 
of hypnotherapy on depression were found using PubMed, Medline, and CINAHL.  
 
Outcomes Measured: Depression was measured through the Beck Depression Inventory (BDI-
II), which is a 21-question multiple choice self-report inventory based on scores of 0-63, with 
higher scores signifying more severe depressive symptoms. Anxiety was measured through the 
Beck Anxiety Inventory (BAI) and hopelessness was measured through the Beck Hopelessness 
Scale (BHS).  
 
Results: In a randomized controlled trial by Alladin and Alibhai, hypnotherapy produced 
significant improvement in BDI-II, BAI, and BHS scores from baseline. In another study by 
Dobbin et al, hypnotherapy was significantly more effective than antidepressant treatment on 
depression. A case study by Loriedo and Torti shifted the view of depression from an 
interpersonal view to include the role of family and cultural influences through hypnotherapy of 
the patient and their family, which resulted in a decrease of depressive symptoms. 
 
Conclusion: The results of the two randomized controlled trials and one case study demonstrate 
that hypnotherapy is an effective treatment for depression.  
 
Keywords: Depression, Hypnotherapy, Hypnosis  
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INTRODUCTION 
Depression is a chronic illness with an increasing incidence over the last century in the 
United States as well as internationally. Depression currently affects over 21 million Americans.1 
The incidence of depression in the United States is 20% in females and 12% in males.2 
Depression costs an estimated $83.1 billion/year in the US. 3 The number of health care visits 
with depression as a primary diagnosis was estimated to be 7.9 million/year. 4 
The exact cause of depression is relatively unknown. However, current evidence suggests 
that the cause is related to neurotransmitter imbalance, with serotonin being an important factor, 
but also including norepinephrine, dopamine, glutamate, and brain-derived neurotrophic factor. 
Stressors and genetic factors also play an important role in the development of depression. 2 
Patients with depression may present with dysphoric mood, anhedonia, irritability, or difficulty 
concentrating. They may also present with somatic complaints such as fatigue, headache, 
abdominal pain, or changes in weight. 2 The diagnostic and statistical manual of mental disorders 
(DSM-IV) lays out the criteria for diagnosing depression. A major depressive episode must 
include a depressed mood and a loss of interest (anhedonia) plus at least three of the following 
symptoms for at least a 2-week period: sleep disturbance, appetite changes, psychomotor 
agitation, fatigue or loss of energy, feelings of worthlessness, diminished ability to think or 
concentrate, and suicidal thoughts. 2  
Current standard therapy for depression includes pharmacotherapy, psychotherapy, and 
electroconvulsive therapy. Psychotherapy treatments include cognitive-behavioral therapy 
(CBT), hypnotherapy, interpersonal therapy or counseling, and family or group therapy. 
Cognitive behavioral therapy is a type of treatment that focuses on changing maladaptive 
thinking in order to improve affect and behavior. Electroconvulsive therapy, which is usually 
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reserved as a treatment for severe depression, involves electric currents being passed through the 
brain, triggering a brief therapeutic clonic seizure, which causes a change in brain chemistry that 
is thought to improve symptoms of mental illnesses.5  
While antidepressant medication and cognitive-behavioral therapy are used as first-line 
treatments for depression, hypnotherapy has also been considered a treatment option. During a 
hypnotherapy session, as a patient is brought into deeper levels of consciousness, their heart rate, 
respiration, and blood pressure decrease. When the patient has reached the deepest level of 
consciousness, he or she can access forgotten memories, painful events, and neglected emotions. 
The hypnotherapist “assists the patient with constructing new, healthier thought processes and 
behaviors to use when mentally encountering the depressive events.” 6 
This paper evaluates two randomized controlled trials and one case study on the 
effectiveness of hypnotherapy for the treatment of depression. 
OBJECTIVE 
The objective of this systematic review is to determine whether or not hypnotherapy is an 
effective treatment for depression. 
METHODS 
Specific criteria were used in the selection of studies in the two randomized controlled 
trials. In the RCT by Alladin and Alibhai7, selection of subjects included patients with chronic 
major depressive disorder based on the DSM-IV who have been treated with antidepressant 
medication for at least 6 months. Exclusion criteria included depressive patients with comorbid 
conditions such as schizophrenia, schizoaffective disorder, current substance abuse, eating 
disorder, bipolar disorder, obsessive-compulsive disorder, organic mental disorder, pervasive 
developmental delay, or personality disorders. With this criteria in mind, 98 patients, 14 of 
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whom withdrew (leaving 84 patients at the end of the trial) were randomly assigned to a 16-week 
treatment of either cognitive-behavioral therapy (CBT) (n= 42) or cognitive hypnotherapy (CH) 
(n=42). After weeks 1 (baseline), 4, 8, 12, 16, 42, and 68, their depressive symptoms were 
measured using the Beck Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI), and 
Beck Hopelessness Scale (BHS). 7  
The intervention used in this studied was cognitive hypnotherapy with the comparison 
group being cognitive-behavioral therapy. Cognitive hypnotherapy consisted of several 
techniques including hypnotic induction, ego-strengthening, expansion of awareness, positive 
mood induction, posthypnotic suggestions, and self-hypnosis. The focus of hypnotic induction 
was on relaxation, somatosensory changes, power of the mind, and increasing the patient’s 
confidence. Expansion of awareness was utilized to amplify experiences of well-being and 
intensify positive feelings. Positive mood induction involved making a list of 10-15 happy 
experiences and practicing holding each experience in mind for approximately 30 seconds. The 
patient was encouraged to replace negative thoughts with a pleasant experience from their list. In 
this way, depressive pathways were replaced with pleasant pathways. Posthypnotic suggestions 
entailed positive reassurance that the patient will recover from depression. Finally, self-hypnosis 
was utilized by giving each patient a prerecorded audiotape of a self-hypnotic procedure that 
consisted of creating a positive frame of mind and ego-strengthening posthypnotic suggestions; 
each patient was instructed to listen to the tape at least once daily. The outcomes addressed were 
depressive symptoms, anxiety, and hopelessness, which were measured with the Beck 
Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI), and Beck Hopelessness Scale 
(BHS). Cognitive-behavioral therapy in this study was based on the manual produced by Beck, 
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Rush, Shaw, and Emery, and is a psychotherapy that focuses on changing maladaptive thoughts 
in order to improve affect and behavior.7  
The partially randomized preference study design by Dobbin et al8 evaluated 58 patients, 
who were allowed to choose either self-hypnosis or anti-depressants as a treatment for their 
depression over a period of 12 weeks. As a result, 50 patients chose self-hypnosis, 4 chose anti-
depressants, and 4 were randomly assigned. Nine of the patients from the self-hypnosis group 
withdrew, leaving 41 patients in that group, with a total of 49 subjects in the trial. The subjects 
chosen were patients between the ages of 18 and 65 who have had a recent episode of depression 
(first attack or recurrence) or were about to have antidepressants prescribed to them. Exclusion 
criteria included patients with bipolar depression, psychoses, current alcohol and drug use, a 
depressive episode in the previous 6 months, or active suicidal ideation. The intervention 
addressed in this study was self-hypnosis, which was compared to antidepressant medication. 
The patients who chose self-hypnosis watched a short film that explained self-hypnosis, listened 
to the first recording, and were given the first CD out of the total 3 CDs, in which each CD 
included 4 sessions. The self-hypnosis was based on Integrated Mental Training, an audio-based 
program by Lars Eric Unestahl. The group who chose antidepressants were prescribed 
antidepressant by their general practitioners and instructed to fill their prescriptions and begin 
taking the medicine. The outcomes addressed were depressive symptoms, which were measured 
with the Beck Depression Inventory (BDI-II) and Brief Symptom Inventory (BSI). 8 
The case study by Loriedo and Torti9 used systemic hypnotherapy on the depressed 
patient as well as his or her family in the same session. This systemic hypnotherapy attempted to 
understand depression as a complex series of interactions, where depression is not simply a 
personal emotional disorder but an interpersonal disorder that is influenced by relationship 
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patterns. The population studied included a 38-year-old husband and his depressed wife, a 61-
year-old depressed dad and his 32-year-old son, and a 35-year-old depressed woman and her 
parents and sister. The outcomes addressed were depressive symptoms and overall well-being. 9 
Key words used in this search were “depression”, “hypnotherapy”, and “hypnosis”. All 
articles were published in peer-reviewed journals and in the English language. The author 
researched the articles in PubMed, Medline, and CINAHL. The articles were selected based on 
their relevance to the clinical question and on their importance of outcomes to patients (POEMs). 
Inclusion criteria included studies that were randomized, controlled, and included patient 
oriented outcomes. Exclusion criteria included studies that were dated before 1996 and whose 
outcomes were not patient oriented. The statistics used in the studies were ANOVA and t-scores. 
Table 1: Demographics of included studies 
Study Type # 
of 
pts 
Age Inclusion Criteria Exclusion 
Criteria 
W/D Interventions 
Alladin, 
Alibhai, 
2007 
RCT 98 23-47 Patients with 
chronic major 
depressive disorder 
who have been 
treated with 
antidepressant 
medication for at 
least 6 months 
Depressive 
patients 
with 
comorbid 
conditions 
14 Cognitive 
hypnotherapy 
and cognitive-
behavioral 
therapy 
Dobbin 
et al, 
2009 
Partially 
randomized 
preference 
study 
design 
58 18-65 Patients who have 
had a recent 
episode of 
depression or who 
were about to have 
antidepressants 
prescribed to them 
Depressive 
patients 
with 
comorbid 
conditions 
or active 
suicidal 
ideation 
9 Self-hypnosis 
and anti-
depressant 
medication 
Loriedo, 
2010 
Case Study 3 35-61 Families with one 
or more members 
who is diagnosed 
with depression 
N/A 0 Systemic 
hypnosis in a 
group setting 
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OUTCOMES MEASURED 
The outcomes measured in these studies were depressive symptoms, anxiety, and 
hopelessness using the Beck Depression Inventory (BDI-II), the Beck Anxiety Inventory (BAI), 
and the Beck Hopelessness Scale (BHS). The BDI-II is a 21-question multiple choice self-report 
based on scores of 0-63, with higher scores signifying more severe depressive symptoms. A 
score of 0-13 indicates minimal depression, 14-19 indicates mild depression, 20-28 indicates 
moderate depression, and 29-63 indicates severe depression.10  
Depressive symptoms were also measured using the Brief Symptom Inventory (BSI), a 
53-question self-report that assesses psychological distress and psychiatric disorders through 9 
subscales: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid ideation, and psychoticism. 11 The BSI is scored based on the 
Global Severity Index (GSI), which helps “quantify a patient's severity-of-illness and provides a 
score for measuring the outcome of a treatment program based on reducing symptom severity.” 
In addition, SF-36, a 36-question health survey that measures physical and mental health, was 
used to quantify outcomes. 12 The SF-36 contains 8 scaled scores including vitality, physical 
functioning, bodily pain, general health perceptions, physical role functioning, emotional role 
functioning, social role functioning, and mental health. 12 
RESULTS 
The two randomized control trials and one case study reviewed studied the effects of 
hypnotherapy on depression. In the RCT by Alladin and Alibhai7, ANOVA results indicated that 
there were no significant differences between Beck scores of participants in the CH or CBT 
treatment groups at baseline. At the termination of treatment (week 16), paired t tests 
demonstrated that subjects in the CH group had significantly lower BDI-II scores t(41) = 15.9,   
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p <.001, BAI scores t(41) = 12.2, p < .001, and BHS scores t(41) = 12.4, p <.001 compared to 
baseline. Participants in the CBT group also had significantly lower BDI-II scores t(41) = 14.5, p 
< .001, BAI scores t(41) = 13.0, p < .001, and BHS t(41) = 13.3, p <.001 at termination from 
baseline.  However, it was discovered that the CH group displayed significantly greater changes 
in Beck scores at termination of therapy from baseline than the CBT group: BDI-II, t(82) =         
-2.66, p = .009; BAI, t(82) = -3.22, p = .002; BHS, t(82) = -3.35, p = .001. The CH group also 
presented with lower BDI-II scores at week 42 and week 68 than the CBT group, but the article 
failed to report if those results were significant. Moreover, the CH group displayed significantly 
lower anxiety than the CBT group at follow-up week 42, BAI t(80) = -3.24, p = .002, and week 
68, BAI t(72) = -3.08, p = .003. There was no statistical significance of hopelessness scores 
between the CH and CBT group at week 42. However, the CH group displayed significantly 
lower hopelessness scores than the CBT group at week 68, t(72) = -2.27, p = .026. This indicates 
that participants in the CH group continued to listen to their self-hypnosis tapes even after 
treatment which helped in the maintenance of their reduced depressive symptoms.7 This study 
failed to report safety issues with hypnotherapy. 
Table 2: Paired t test Results at Termination (week 16) Compared to Baseline of CH and 
CBT Groups 
 BDI-II BAI BHS 
CH t(41) = 15.9, p <.001 t(41) = 12.2, p < .001 t(41) = 12.4, p <.001 
CBT t(41) = 14.5, p < .001 t(41) = 13.0, p < .001 t(41) = 13.3, p <.001 
 
Table 3: Paired t test Results of CH compared to CBT Groups at Termination (week 16), 
Week 42, and Week 68. 
 BDI-II BAI BHS 
Termination (week 16) t(82) = -2.66, p = .009 t(82) = -3.22, p = .002 t(82) = -3.35, p = .001 
Week 42 Not reported t(80) = -3.24, p = .002 No statistical significance 
Week 68 Not reported t(72) = -3.08, p = .003 t(72) = -2.27, p = .026 
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The partially randomized preference study design by Dobbin et al8 demonstrated that BDI 
and BSI scores were statistically significant between the self-hypnosis and anti-depressant 
medication groups at the termination of treatment (week 12), BDI p = .004, BSI p = .012, with 
self-hypnosis being significantly more effective than antidepressant medication in the treatment 
of depression. Tables 4 and 5 illustrate BDI and BSI scores at intake and at the end of treatment. 
The self-hypnosis and antidepressant medication group were also compared using the SF-36, 
which demonstrated significant differences in general health (p = .012, 95% CI for effect size 
5.1and 37.9) and vitality (p = .003, CI 10.3 and 46.6).  Because the groups were not randomized 
but selected by preference of the participants, there was “some degree of adjusting for baseline 
factors in the analysis using multiple regression.” However, the treatment remained statistically 
significant, and the results from the t test were not explained by imbalance at baseline. The two 
randomized self-hypnosis and antidepressant medication groups could not be compared because 
there were only 4 subjects across the two groups. There were no adverse events with either self-
hypnosis or anti-depressant medication subjects and no hospital admissions.8 
Table 4: BDI and BSI Scores at Intake (Week 1) 
 BDI BSI 
Self-Hypnosis  29.5 1.81 
Anti-depressant medication 34.2 1.92 
 
Table 5: BDI and BSI Scores at Termination (Week 12) 
 BDI BSI 
Self-Hypnosis 9.9 0.5 
Anti-depressant medication 24 1.33 
 
The case study by Loriedo and Torti9 using systemic hypnosis on depressed patients and 
their families demonstrated significant improvement in both the depressed patient and in the 
quality of the relationship. The hypnotherapy session between Guido, a 38-year-old male, and his 
depressed wife, Giulia, allowed them to openly discuss difficulties in their relationship and 
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previously unsaid emotions towards one another. The hypnotherapy made it possible for both of 
them to say what was on their minds and to restore their relationship. “Giulia’s sense of isolation, 
hopelessness, and depression was replaced with a renewed sense of purpose about her 
marriage.”9 In addition, Guido was able to understand why his wife was feeling certain emotions 
and allowed them to begin to improve their relationship.9 
Another hypnotherapy session allowed a 61-year-old father, Antonio, and his 32-year-old 
son, Aldo, who no longer spoke to each other to restore their relationship by talking out their 
concerns and anxieties about one another. After the hypnosis session, they were able to finally 
reconnect. Hypnosis allows people to speak to each other in a very open and special way, unlike 
any other way method.9 
A third hypnotherapy session was conducted between a 35-year-old female, Carla, her 
parents, and her sister. After about 5 hypnotherapy sessions between Carla and her family, Carla 
“reported feeling much better, finally having unloaded the burden of her troubled dishonest 
relationship with her family. She was not only able to finally smile spontaneously but she also 
began to share a sense of humor that never appeared before.” 9 
DISCUSSION 
This systematic review investigated two RCTs and one case study for the effectiveness of 
hypnotherapy as a treatment for depression. These three studies demonstrated that hypnotherapy 
is an effective treatment for depression. The RCT by Alladin and Alibai7 confirmed that although 
CH and CBT generated a significant decrease in depressive symptoms at termination and follow-
ups from baseline, CH produced significantly larger results than CBT at termination and both 
follow-ups. Unfortunately, because CH was composed of several components, it is impossible to 
determine which components had the greatest effects. The study also found that when 
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hypnotherapy was used in combination with CBT, it produced greater improvements in 
depressive symptoms than CBT alone.7 
 The study by Dobbin et al8 illustrated that self-hypnosis was significantly more effective 
than antidepressant medication in the treatment of depressed patients. However, patients were 
allowed to select whether they preferred to be in the hypnotherapy or anti-depressant medication 
group, which created a bias in the groups. Nonetheless, this bias was “addressed to some degree 
by adjusting for baseline factors in the analysis using multiple regression.”8 In addition, the 
hypnotherapy and medication groups that were randomized were too small to be analyzed. 
Developing a truly randomized control study between hypnotherapy and anti-depressant 
medication groups, rather than allowing for patient preference, would have produced more 
reliable and unbiased results. 
 The case studies on systemic hypnosis with depressed patients and their families revealed 
that hypnosis allowed individuals to openly and freely share thoughts and emotions with 
significant others in order to restore their relationship.9 Depression is thought of as an 
interpersonal disorder, rather than a personal struggle, and is influenced by relationship patterns 
and interactions. As a result, bringing all parties into the hypnosis session is a thorough and 
effective means of treating depression. 
 Depression is a chronic and debilitating disorder that affects millions of lives worldwide. 
An effective treatment for depression will allow many to return to normal living, free of 
depressive symptoms. There are numerous patients who refuse medication or whose 
antidepressant medication has adverse effects or dangerous interactions with other medications. 
In addition, antidepressants may take a great deal of time to produce a significant effect or may 
not have an effect at all. Regimens have to be adjusted and could take weeks to months to work. 
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In these instances, an alternative treatment, such as hypnotherapy, would be appropriate. In fact, 
the partially randomized preference design study by Dobbin et al demonstrated that significantly 
more patients preferred self-hypnosis to medication for the treatment of depression. 
 Hypnotherapy typically costs between $75-$125 per session, with sessions usually lasting 
between an hour and an hour and a half.13 Many insurance companies do not cover hypnosis 
services but will cover anti-depressant medications. Therefore, this poses a limitation on 
hypnotherapy as a treatment for depression unless patients are willing and able to pay for 
hypnosis services out-of-pocket. 
CONCLUSION 
After reviewing the two RCTs and one case study, the results demonstrated that 
hypnotherapy is an effective treatment for depression. The studies also revealed that 
hypnotherapy is more effective in treating depression than anti-depressants or cognitive-
behavioral therapy. Future studies should be performed comparing hypnotherapy and anti-
depressants using randomized groups rather than preference groups. This will eliminate bias and 
provide more significant results. Future studies would also benefit from using single aspects of 
cognitive hypnotherapy to treat depression in order to view the results of each specific method.  
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